Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies

Paul Brennan(Centre International de Recherche sur le Cancer), O Bogillot(Centre International de Recherche sur le Cancer), Sylvaine Cordier, Eberhard Greiser(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Walter Schill(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Paolo Vineis(University of Turin), Gonzalo López‐Abente(Centro Nacional de Epidemiología), Αναστασία Τζώνου(Athens Medical Center), Jenny Chang‐Claude(German Cancer Research Center), Ulrich Bolm‐Audorff(Hessian Ministry for Social Affairs and Integration), Karl-Heinz J�ckel(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Francesco Donato(University of Brescia), Cònsol Serra, Jorgen Wahrendorf(German Cancer Research Center), Martine Hours(Université Claude Bernard Lyon 1), Andrea ’t Mannetje(Centre International de Recherche sur le Cancer), Manolis Kogevinas(Municipal Institute for Medical Research), Paolo Boffetta(Centre International de Recherche sur le Cancer)
International Journal of Cancer
April 15, 2000
Cited by 377

Abstract

The primary risk factor for bladder cancer is cigarette smoking. Using a combined analysis of 11 case-control studies, we have accurately measured the relationship between cigarette smoking and bladder cancer in men. Available smoking information on 2,600 male bladder cancer cases and 5,524 male controls included duration of smoking habit, number of cigarettes smoked per day and time since cessation of smoking habit for ex-smokers. There was a linear increasing risk of bladder cancer with increasing duration of smoking, ranging from an odds ratio (OR) of 1.96 after 20 years of smoking (95% confidence interval [CI] 1.48-2.61) to 5.57 after 60 years (CI 4.18-7.44). A dose relationship was observed between number of cigarettes smoked per day and bladder cancer up to a threshold limit of 15-20 cigarettes per day, OR = 4.50 (CI 3.81-5. 33), after which no increased risk was observed. An immediate decrease in risk of bladder cancer was observed for those who gave up smoking. This decrease was over 30% after 1-4 years, OR = 0.65 (0. 53-0.79), and was over 60% after 25 years of cessation, OR = 0.37 (0. 30-0.45). However, even after 25 years, the decrease in risk did not reach the level of the never-smokers, OR = 0.20. (0.17-0.24). The proportion of bladder cancer cases attributable to ever-smoking was 0.66 (0.61-0.70) for all men and 0.73 (0.66-0.79) for men younger than 60. These estimates are higher than previously calculated.


Related Papers

No related papers found

Powered by citation graph analysis